Other Species / Isoforms
  YB-1 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MssEAETQQ
Upstream
0 8
Treatment
  • insulin
  • LY294002
  • MK-2206
YB-1 (human) ______MssEAEtQQ S2-p
YB-1 (mouse) ______MssEAETQQ S2-p
YB-1 (rat) ______MsSEAETQQ S2-p
S3-p
_____MssEAETQQP
Upstream
0 7
Treatment
  • insulin
  • LY294002
  • MK-2206
YB-1 (human) _____MssEAEtQQP S3-p
YB-1 (mouse) _____MssEAETQQP S3-p
YB-1 (rat) _____MsSEAETQQP S3
T7
_MssEAETQQPPAAP
0 1
YB-1 (human) _MssEAEtQQPPAAP T7-p
YB-1 (mouse) _MssEAETQQPPAAP T7
YB-1 (rat) _MsSEAETQQPPAAP T7
S19-p
AAPAAALsAADTkPG
0 3
YB-1 (human) PPAAPALsAADTkPG S21-p
YB-1 (mouse) AAPAAALsAADTkPG S19-p
YB-1 (rat) AAPAAALSAADTKPG S19
K24-ub
ALsAADTkPGsTGsG
0 6
YB-1 (human) ALsAADTkPGTTGsG K26-ub
YB-1 (mouse) ALsAADTkPGsTGsG K24-ub
YB-1 (rat) ALSAADTKPGSTGSG K24
S27-p
AADTkPGsTGsGAGs
0 1
YB-1 (human) AADTkPGTTGsGAGs T29
YB-1 (mouse) AADTkPGsTGsGAGs S27-p
YB-1 (rat) AADTKPGSTGSGAGS S27
S30-p
TkPGsTGsGAGsGGP
0 2
YB-1 (human) TkPGTTGsGAGsGGP S32-p
YB-1 (mouse) TkPGsTGsGAGsGGP S30-p
YB-1 (rat) TKPGSTGSGAGSGGP S30
S34-p
sTGsGAGsGGPGGLT
0 4
YB-1 (human) TTGsGAGsGGPGGLT S36-p
YB-1 (mouse) sTGsGAGsGGPGGLT S34-p
YB-1 (rat) STGSGAGSGGPGGLt S34
T41
sGGPGGLTSAAPAGG
0 1
YB-1 (human) sGGPGGLTsAAPAGG T43
YB-1 (mouse) sGGPGGLTSAAPAGG T41
YB-1 (rat) SGGPGGLtsAAPAGG T41-p
S42
GGPGGLTSAAPAGGD
0 2
YB-1 (human) GGPGGLTsAAPAGGD S44-p
YB-1 (mouse) GGPGGLTSAAPAGGD S42
YB-1 (rat) GGPGGLtsAAPAGGD S42-p
K50
AAPAGGDKKVIATkV
0 1
YB-1 (human) AAPAGGDkKVIATkV K52-ub
YB-1 (mouse) AAPAGGDKKVIATkV K50
YB-1 (rat) AAPAGGDKKVIATKV K50
K56-ub
DKKVIATkVLGTVkW
0 4
YB-1 (human) DkKVIATkVLGTVkW K58-ub
YB-1 (mouse) DKKVIATkVLGTVkW K56-ub
YB-1 (rat) DKKVIATKVLGTVKW K56
K62
TkVLGTVKWFNVRNG
0 7
YB-1 (human) TkVLGTVkWFNVRNG K64-ac
YB-1 (mouse) TkVLGTVKWFNVRNG K62
YB-1 (rat) TKVLGTVKWFNVRNG K62
K62-ub
TkVLGTVkWFNVRNG
0 17
YB-1 (human) TkVLGTVkWFNVRNG K64-ub
YB-1 (mouse) TkVLGTVkWFNVRNG K62-ub
YB-1 (rat) TKVLGTVKWFNVRNG K62
T78-p
GFINRNDtkEDVFVH
0 5
YB-1 (human) GFINRNDtkEDVFVH T80-p
YB-1 (mouse) GFINRNDtkEDVFVH T78-p
YB-1 (rat) GFINRNDTkEDVFVH T78
K79
FINRNDtKEDVFVHQ
0 3
YB-1 (human) FINRNDtkEDVFVHQ K81-ac
YB-1 (mouse) FINRNDtKEDVFVHQ K79
YB-1 (rat) FINRNDTkEDVFVHQ K79-ac
K79-ub
FINRNDtkEDVFVHQ
0 22
YB-1 (human) FINRNDtkEDVFVHQ K81-ub
YB-1 (mouse) FINRNDtkEDVFVHQ K79-ub
YB-1 (rat) FINRNDTKEDVFVHQ K79
K90-ub
FVHQTAIkkNNPRKY
0 116
YB-1 (human) FVHQTAIkkNNPRKy K92-ub
YB-1 (mouse) FVHQTAIkkNNPRKY K90-ub
YB-1 (rat) FVHQTAIKKNNPRKY K90
K91-ub
VHQTAIkkNNPRKYL
0 44
YB-1 (human) VHQTAIkkNNPRKyL K93-ub
YB-1 (mouse) VHQTAIkkNNPRKYL K91-ub
YB-1 (rat) VHQTAIKKNNPRKYL K91
Y97
kkNNPRKYLRsVGDG
1 5
YB-1 (human) kkNNPRKyLRsVGDG Y99-p
YB-1 (mouse) kkNNPRKYLRsVGDG Y97
YB-1 (rat) KKNNPRKYLRsVGDG Y97
S100-p
NPRKYLRsVGDGEtV
Upstream
11 34
YB-1 (human)
S102-p
YB-1 (mouse)
S100-p
YB-1 (rat)
S100-p
Regulatory protein:
  • FLT3 (mouse)
Treatment
  • insulin
  • LY294002
YB-1 (human) NPRKyLRsVGDGEtV S102-p
YB-1 (mouse) NPRKYLRsVGDGEtV S100-p
YB-1 (rat) NPRKYLRsVGDGETV S100-p
T106-p
RsVGDGEtVEFDVVE
0 2
YB-1 (human) RsVGDGEtVEFdVVE T108-p
YB-1 (mouse) RsVGDGEtVEFDVVE T106-p
YB-1 (rat) RsVGDGETVEFDVVE T106
D110
DGEtVEFDVVEGEKG
0 1
YB-1 (human) DGEtVEFdVVEGEkG D112-ca
YB-1 (mouse) DGEtVEFDVVEGEKG D110
YB-1 (rat) DGETVEFDVVEGEKG D110
K116
FDVVEGEKGAEAANV
0 5
YB-1 (human) FdVVEGEkGAEAANV K118-ub
YB-1 (mouse) FDVVEGEKGAEAANV K116
YB-1 (rat) FDVVEGEKGAEAANV K116
S134
GGVPVQGSkYAADRN
0 1
YB-1 (human) GGVPVQGskYAADrN S136-p
YB-1 (mouse) GGVPVQGSkYAADRN S134
YB-1 (rat) GGVPVQGSkYAADRN S134
K135-ac
GVPVQGSkYAADRNH
0 3
YB-1 (human) GVPVQGskYAADrNH K137-ac
YB-1 (mouse) GVPVQGSkYAADRNH K135-ac
YB-1 (rat) GVPVQGSkYAADRNH K135-ac
K135-ub
GVPVQGSkYAADRNH
0 92
YB-1 (human) GVPVQGskYAADrNH K137-ub
YB-1 (mouse) GVPVQGSkYAADRNH K135-ub
YB-1 (rat) GVPVQGSKYAADRNH K135
R140
GSkYAADRNHyRRYP
0 11
YB-1 (human) GskYAADrNHyRRYP R142-m1
YB-1 (mouse) GSkYAADRNHyRRYP R140
YB-1 (rat) GSkYAADRNHYRRYP R140
Y143-p
YAADRNHyRRYPRRR
0 49
YB-1 (human) YAADrNHyRRYPRRR Y145-p
YB-1 (mouse) YAADRNHyRRYPRRR Y143-p
YB-1 (rat) YAADRNHYRRYPRRR Y143
Y156-p
RRGPPRNyQQNyQNs
0 157
YB-1 (human) RRGPPRNyQQNyQNs Y158-p
YB-1 (mouse) RRGPPRNyQQNyQNs Y156-p
YB-1 (rat) RRGPPRNYQQNYQNs Y156
Y160-p
PRNyQQNyQNsEsGE
0 340
YB-1 (human) PRNyQQNyQNsEsGE Y162-p
YB-1 (mouse) PRNyQQNyQNsEsGE Y160-p
YB-1 (rat) PRNYQQNYQNsEsGE Y160
S163-p
yQQNyQNsEsGEkNE
Upstream
2 108
Regulatory protein:
  • leptin (mouse)
Treatment
  • LPA
  • PDGF
YB-1 (human) yQQNyQNsEsGEkNE S165-p
YB-1 (mouse) yQQNyQNsEsGEkNE S163-p
YB-1 (rat) YQQNYQNsEsGEKNE S163-p
S165-p
QNyQNsEsGEkNEGs
Upstream
0 64
Treatment
  • LPA
  • PDGF
YB-1 (human) QNyQNsEsGEkNEGs S167-p
YB-1 (mouse) QNyQNsEsGEkNEGs S165-p
YB-1 (rat) QNYQNsEsGEKNEGs S165-p
K168-ub
QNsEsGEkNEGsEsA
0 59
YB-1 (human) QNsEsGEkNEGsEsA K170-ub
YB-1 (mouse) QNsEsGEkNEGsEsA K168-ub
YB-1 (rat) QNsEsGEKNEGsEsA K168
S172-p
sGEkNEGsEsAPEGQ
Upstream
1 97
Treatment
  • LPA
  • PDGF
YB-1 (human) sGEkNEGsEsAPEGQ S174-p
YB-1 (mouse) sGEkNEGsEsAPEGQ S172-p
YB-1 (rat) sGEKNEGsEsAPEGQ S172-p
S174-p
EkNEGsEsAPEGQAQ
Upstream
1 95
Treatment
  • PDGF
YB-1 (human) EkNEGsEsAPEGQAQ S176-p
YB-1 (mouse) EkNEGsEsAPEGQAQ S174-p
YB-1 (rat) EKNEGsEsAPEGQAQ S174-p
R183
PEGQAQQRRPYrRRR
0 2
YB-1 (human) PEGQAQQrrPyrrRr R185-m1
YB-1 (mouse) PEGQAQQRRPYrRRR R183
YB-1 (rat) PEGQAQQrRPYRRRR R183-m1
R184
EGQAQQRRPYrRRRF
0 1
YB-1 (human) EGQAQQrrPyrrRrF R186-m1
YB-1 (mouse) EGQAQQRRPYrRRRF R184
YB-1 (rat) EGQAQQrRPYRRRRF R184
Y186
QAQQRRPYrRRRFPP
1 0
YB-1 (human) QAQQrrPyrrRrFPP Y188-p
YB-1 (mouse) QAQQRRPYrRRRFPP Y186
YB-1 (rat) QAQQrRPYRRRRFPP Y186
R187-m1
AQQRRPYrRRRFPPY
0 2
YB-1 (human) AQQrrPyrrRrFPPy R189-m1
YB-1 (mouse) AQQRRPYrRRRFPPY R187-m1
YB-1 (rat) AQQrRPYRRRRFPPY R187
R188
QQRRPYrRRRFPPYY
0 1
YB-1 (human) QQrrPyrrRrFPPyy R190-m1
YB-1 (mouse) QQRRPYrRRRFPPYY R188
YB-1 (rat) QQrRPYRRRRFPPYY R188
R190
RRPYrRRRFPPYYMr
0 7
YB-1 (human) rrPyrrRrFPPyyMr R192-m1
YB-1 (mouse) RRPYrRRRFPPYYMr R190
YB-1 (rat) rRPYRRRRFPPYYMR R190
Y194
rRRRFPPYYMrRPYA
0 15
YB-1 (human) rrRrFPPyyMrrPYG Y196-p
YB-1 (mouse) rRRRFPPYYMrRPYA Y194
YB-1 (rat) RRRRFPPYYMRRPYA Y194
Y195
RRRFPPYYMrRPYAR
0 9
YB-1 (human) rRrFPPyyMrrPYGr Y197-p
YB-1 (mouse) RRRFPPYYMrRPYAR Y195
YB-1 (rat) RRRFPPYYMRRPYAR Y195
R197-m1
RFPPYYMrRPYARRP
0 40
YB-1 (human) rFPPyyMrrPYGrrP R199-m1
YB-1 (mouse) RFPPYYMrRPYARRP R197-m1
YB-1 (rat) RFPPYYMRRPYARRP R197
R197
RFPPYYMRRPYARRP
0 1
YB-1 (human) rFPPyyMrrPYGrrP R199-m2
YB-1 (mouse) RFPPYYMRRPYARRP R197
YB-1 (rat) RFPPYYMRRPYARRP R197
R198
FPPYYMrRPYARRPQ
0 7
YB-1 (human) FPPyyMrrPYGrrPQ R200-m1
YB-1 (mouse) FPPYYMrRPYARRPQ R198
YB-1 (rat) FPPYYMRRPYARRPQ R198
R202
YMrRPYARRPQysNP
0 3
YB-1 (human) yMrrPYGrrPQysNP R204-m1
YB-1 (mouse) YMrRPYARRPQysNP R202
YB-1 (rat) YMRRPYARRPQYsNP R202
R203
MrRPYARRPQysNPP
0 1
YB-1 (human) MrrPYGrrPQysNPP R205-m1
YB-1 (mouse) MrRPYARRPQysNPP R203
YB-1 (rat) MRRPYARRPQYsNPP R203
Y206-p
PYARRPQysNPPVQG
0 173
YB-1 (human) PYGrrPQysNPPVQG Y208-p
YB-1 (mouse) PYARRPQysNPPVQG Y206-p
YB-1 (rat) PYARRPQYsNPPVQG Y206
S207-p
YARRPQysNPPVQGE
Upstream
0 33
Treatment
  • insulin
  • LPS
YB-1 (human) YGrrPQysNPPVQGE S209-p
YB-1 (mouse) YARRPQysNPPVQGE S207-p
YB-1 (rat) YARRPQYsNPPVQGE S207-p
R229
QGAGEQGRPVRQNMY
0 1
YB-1 (human) QGAGEQGrPVrQNMy R231-m1
YB-1 (mouse) QGAGEQGRPVRQNMY R229
YB-1 (rat) QGAGEQGRPVRQNMY R229
R232
GEQGRPVRQNMYrGY
0 1
YB-1 (human) GEQGrPVrQNMyrGY R234-m1
YB-1 (mouse) GEQGRPVRQNMYrGY R232
YB-1 (rat) GEQGRPVRQNMYRGY R232
Y236
RPVRQNMYrGYRPRF
0 5
YB-1 (human) rPVrQNMyrGYrPrF Y238-p
YB-1 (mouse) RPVRQNMYrGYRPRF Y236
YB-1 (rat) RPVRQNMYRGYRPRF Y236
R237-m1
PVRQNMYrGYRPRFR
0 14
YB-1 (human) PVrQNMyrGYrPrFR R239-m1
YB-1 (mouse) PVRQNMYrGYRPRFR R237-m1
YB-1 (rat) PVRQNMYRGYRPRFR R237
R240
QNMYrGYRPRFRRGP
0 7
YB-1 (human) QNMyrGYrPrFRRGP R242-m1
YB-1 (mouse) QNMYrGYRPRFRRGP R240
YB-1 (rat) QNMYRGYRPRFRRGP R240
R242
MYrGYRPRFRRGPPR
0 1
YB-1 (human) MyrGYrPrFRRGPPR R244-m1
YB-1 (mouse) MYrGYRPRFRRGPPR R242
YB-1 (rat) MYRGYRPRFRRGPPR R242
K262-ub
EDGNEEDkENQGDEt
0 37
YB-1 (human) EDGNEEDkENQGDEt K264-ub
YB-1 (mouse) EDGNEEDkENQGDEt K262-ub
YB-1 (rat) EDGNEEDKENQGDET K262
T269-p
kENQGDEtQGQQPPQ
0 23
YB-1 (human) kENQGDEtQGQQPPQ T271-p
YB-1 (mouse) kENQGDEtQGQQPPQ T269-p
YB-1 (rat) KENQGDETQGQQPPQ T269
R277
QGQQPPQRRYRRNFN
0 4
YB-1 (human) QGQQPPQrryRRNFN R279-m1
YB-1 (mouse) QGQQPPQRRYRRNFN R277
YB-1 (rat) QGQQPPQrRYRRNFN R277-m1
R278
GQQPPQRRYRRNFNy
0 1
YB-1 (human) GQQPPQrryRRNFNy R280-m1
YB-1 (mouse) GQQPPQRRYRRNFNy R278
YB-1 (rat) GQQPPQrRYRRNFNY R278
Y279
QQPPQRRYRRNFNyR
1 0
YB-1 (human) QQPPQrryRRNFNyR Y281-p
YB-1 (mouse) QQPPQRRYRRNFNyR Y279
YB-1 (rat) QQPPQrRYRRNFNYR Y279
Y285-p
RYRRNFNyRRRRPEN
0 16
YB-1 (human) ryRRNFNyRRRRPEN Y287-p
YB-1 (mouse) RYRRNFNyRRRRPEN Y285-p
YB-1 (rat) RYRRNFNYRRRRPEN Y285
K294
RRRPENPKPQDGkET
0 1
YB-1 (human) RRRPENPkPQDGkET K296-ac
YB-1 (mouse) RRRPENPKPQDGkET K294
YB-1 (rat) RRRPENPKPQDGKET K294
K294-ub
RRRPENPkPQDGkET
0 5
YB-1 (human) RRRPENPkPQDGkET K296-ub
YB-1 (mouse) RRRPENPkPQDGkET K294-ub
YB-1 (rat) RRRPENPKPQDGKET K294
K299-ub
NPkPQDGkETkAADP
0 41
YB-1 (human) NPkPQDGkETkAADP K301-ub
YB-1 (mouse) NPkPQDGkETkAADP K299-ub
YB-1 (rat) NPKPQDGKETKAADP K299
K302-ub
PQDGkETkAADPPAE
0 67
YB-1 (human) PQDGkETkAADPPAE K304-ub
YB-1 (mouse) PQDGkETkAADPPAE K302-ub
YB-1 (rat) PQDGKETKAADPPAE K302
S311-p
ADPPAENssAPEAEQ
0 13
YB-1 (human) ADPPAENssAPEAEQ S313-p
YB-1 (mouse) ADPPAENssAPEAEQ S311-p
YB-1 (rat) ADPPAENSsAPEAEQ S311
S312-p
DPPAENssAPEAEQG
0 56
YB-1 (human) DPPAENssAPEAEQG S314-p
YB-1 (mouse) DPPAENssAPEAEQG S312-p
YB-1 (rat) DPPAENSsAPEAEQG S312-p